Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2001;54:249-252; doi:10.1136/jcp.54.3.249
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
J Clin Pathol 2001; 54:249-252
© 2001 Journal of Clinical Pathology

Short report

Evidence for loss of heterozygosity of 5q in sporadic haemangiomas: are somatic mutations involved in haemangioma formation?

J N Berg,*, J W Walter,*, U Thisanagayam, M Evans, F Blei, M Waner, A G Diamond, D A Marchuk, M E Porteous

Division of Medical and Molecular Genetics, 8th Floor Guy's Tower, Guy's Hospital, London SE1 9RT, UK
South-East of Scotland Clinical Genetics Service, Western General Hospital, Edinburgh EH4 2XU, UK
Department of Genetics, Duke University, Durham, North Carolina NC27710, USA
Department of Pathology, Sheffield Children's Hospital, Sheffield, UK
Department of Otolarygology, University of Arkansas Medical Centre, Little Rock, Arkansas AR72205, USA
Departments of Pediatrics and Plastic Surgery, New York University Centre, New York NY10016, USA
Department of Microbiology and Immunology, Medical School, University of Newcastle upon Tyne, Newcastle NE2 4HH, UK

Correspondence to:
Dr Berg jonathan.berg{at}kcl.ac.uk

Background/Aims—Haemangiomas are common benign tumours of infancy that consist of rapidly proliferating endothelial cells. A locus for an autosomal dominant predisposition to haemangioma has been identified recently on chromosome 5q. This study aimed to investigate loss of heterozygosity on chromosomes 5 and 9 in haemangiomas.

Methods—Sporadic proliferative phase haemangiomas were microdissected. Polymerase chain reaction amplification and analysis of microsatellite markers on chromosomes 5 and 9 was carried out.

Results—There was a significant loss of heterozygosity for markers on chromosome 5q in haemangioma tissue, when compared with either markers from chromosome 5p (p < 0.05) or markers from chromosome 9 (p < 0.05).

Conclusions—These results suggest that haemangioma formation might be associated with somatic mutational events, and provides evidence that a locus on 5q is involved in the formation of sporadic haemangiomas.

Key Words: haemangioma • loss of heterozygosity • chromosome 5


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Calicchio, M. L., Collins, T., Kozakewich, H. P. (2009). Identification of Signaling Systems in Proliferating and Involuting Phase Infantile Hemangiomas by Genome-Wide Transcriptional Profiling. Am. J. Pathol. 174: 1638-1649 [Abstract] [Full Text]  
  • Smolinski, K. N., Yan, A. C. (2005). Hemangiomas of Infancy: Clinical and Biological Characteristics. CLIN PEDIATR 44: 747-766 [Abstract]  
  • Tille, J.-C., Pepper, M.S. (2004). Hereditary Vascular Anomalies: New Insights Into Their Pathogenesis. Arterioscler. Thromb. Vasc. Bio. 24: 1578-1590 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs